Potential risk analysis of antipsychotics-related constipation from the FDA Adverse Event Reporting System

Background Antipsychotics-related constipation is a frequently neglected and poorly researched adverse effects in patients in clinical practice. Constipation not only affects the physical health of patients, but also increases the psychological stress to their disease burden, so it requires our more attention.